We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $5.12B
1-Year Est. Return 314.02%
This Fund
S&P 500
This Quarter Est. Return
+8.13%
1 Year Est. Return
+314.02%
3 Year Est. Return
+1,498.66%
5 Year Est. Return
+2,457.67%
10 Year Est. Return
+48,821.41%
AUM
$988M
AUM Growth
-$31.3M
Cap. Flow
-$56.5M
Cap. Flow %
-5.72%
Top 10 Hldgs %
45.25%
Holding
164
New
47
Increased
25
Reduced
25
Closed
38

Top Buys

Rank Stock Value
1
OTIC
Otonomy, Inc.
OTIC
+$16.6M
2
AEGR
Aegerion Pharmaceuticals
AEGR
+$11.4M
3
ARWR icon
Arrowhead Research
ARWR
+$11.3M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$10.4M
5
EPZM
Epizyme, Inc
EPZM
+$7.5M

Top Sells

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$37M
2
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$24.1M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$21.9M
4
SHPG
Shire pic
SHPG
+$21.2M
5
INSM icon
Insmed
INSM
+$18.1M

Sector Composition

Rank Sector Weight
1 Healthcare 79.83%
2 Financials 0.18%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
126
CALL
Exelixis
EXEL
$13.9B
– –
-400,000
Closed -$1.36M
HUM icon
127
Humana
HUM
$43.9B
– –
-803
Closed -$103K
ICAD
128
DELISTED
iCAD Inc
ICAD
– –
-150,000
Closed -$962K
INCY icon
129
Incyte
INCY
$25.8B
– –
-20,000
Closed -$1.13M
IQV icon
130
IQVIA
IQV
$40.7B
– –
-1,875
Closed -$100K
KPTI icon
131
Karyopharm Therapeutics
KPTI
$155M
– –
-3,043
Closed -$2.13M
MBOT icon
132
Microbot Medical
MBOT
$112M
– –
-168
Closed -$551K
MDT icon
133
Medtronic
MDT
$112B
– –
-130,000
Closed -$8.29M
MOH icon
134
Molina Healthcare
MOH
$10.4B
– –
-2,380
Closed -$106K
NUWE icon
135
Nuwellis
NUWE
$174K
– –
0
– -$140K
RDNT icon
136
RadNet
RDNT
$4.98B
– –
-22,975
Closed -$152K
VRTX icon
137
PUT
Vertex Pharmaceuticals
VRTX
$123B
– –
-30,000
Closed -$2.84M
WBA
138
CALL
DELISTED
Walgreens Boots Alliance
WBA
– –
-50,000
Closed -$3.71M
LUMO
139
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-5,556
Closed -$1.33M
ICPT
140
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-20,000
Closed -$4.73M
ATHX
141
DELISTED
Athersys, Inc. Common Stock
ATHX
– –
-24,074
Closed -$1.08M
ARNA
142
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-3,000
Closed -$176K
BSTC
143
DELISTED
BioSpecifics Technologies Corp.
BSTC
– –
-3,700
Closed -$100K
WCG
144
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-1,302
Closed -$97K
TSRO
145
PUT
DELISTED
TESARO, Inc.
TSRO
– –
-100,000
Closed -$3.11M
PMC
146
DELISTED
PharMerica Corporation
PMC
– –
-3,441
Closed -$98K
ZLTQ
147
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
– –
-201,628
Closed -$3.06M
AEGR
148
CALL
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-100,000
Closed -$3.21M
TBRA
149
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
– –
-95,556
Closed -$5.84M
HNT
150
DELISTED
HEALTH NET INC
HNT
– –
-6,025
Closed -$250K
3 4 5
6
7

Similar funds

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $5.13B AUM 22.98% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return

Perceptive Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Perceptive Advisors held 164 positions worth $988M, down 3.1% from $1.02B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Perceptive Advisors withdrew a net $56.5M in Q3 2014, closing 38 positions and reducing 25 holdings. Its most notable exit was QUESTCOR PHARMA INC, an estimated $37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 81% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Perceptive Advisors opened a new position in Otonomy, Inc. worth $20.1M.

  • Perceptive Advisors's largest Q3 2014 buy was Otonomy, Inc.: 837,400 shares worth $20.1M.
  • Perceptive Advisors added most to Arrowhead Research in Q3 2014, an estimated $11.3M increase.
  • Perceptive Advisors's biggest Q3 2014 reduction was Taro Pharmaceutical Industries Ltd., cutting an estimated $24.1M.
  • Perceptive Advisors fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $37M.
  • Perceptive Advisors's ten largest holdings make up 45% of its $988M portfolio in Q3 2014.
  • Perceptive Advisors opened 47 new positions and closed 38 in Q3 2014.
  • Perceptive Advisors's portfolio value fell 3.1% quarter-over-quarter to $988M.

Based on Perceptive Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.